Cambridge-based biopharmaceutical company Sage Therapeutics filed a lawsuit against their partner, the biotechnology company ...
Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...
The School of Medicine is a major international centre for teaching and research, and committed to the pursuit of improved human health. We combine progressive healthcare education and patient care ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and (Nasdaq: BIIB, Corporate headquarters: Cambridge, ...
We address global challenges such as: Dr Mahfuz Kamal has been awarded an Enterprise Fellowship by the Royal Academy of Engineering to support him as CEO of University spin-out company RecoVolt. The ...
HonorHealth announced the creation of its new international Center for Translational Science. Sanofi said it will repurchase $5.2 billion of stock and grow profits faster this year as the drugmaker ...
Investors in Biogen Inc (Symbol: BIIB) saw new options begin trading today, for the March 2026 expiration. One of the key data points that goes into the price an option buyer is willing to pay ...
Lasell University president Eric Turner is hoping that many Lasell students will find success in the real world by spending plenty of time in a virtual one.
A new study led by Western researchers found frequent treatment with intranasal oxytocin – a hormone in the brain associated with empathy – offers promise for addressing a key symptom among patients ...
Sage Therapeutics knows it needs to do something. But it doesn’t want to sell to its partner Biogen.
Presenting 24 images of cells, tissues and organisms, scientists at the Multiscale Imaging Centre of the University of Münster offer insights into their research. Additionally, a twelve-metre-high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback